A comparative study on the efficacy of the new quinolone alatrofloxacin in the treatment of experimental legionellosis in guinea pigs

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 17, Issue 6, 1998, Pages 420-423

  Garcia de Lomas J ^a   Millas E ^a   Lazaro M A ^a   Bermejo, M ^a   Gimeno, C ^a   Navarro, D ^a   Sanchez S ^b  

^a UNIVERSITY OF VALENCIA   (Spain)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALATROFLOXACIN; ERYTHROMYCIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; TROVAFLOXACIN; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; GUINEA PIG; INTRAPERITONEAL DRUG ADMINISTRATION; LEGIONELLA PNEUMOPHILA; LEGIONNAIRE DISEASE; LUNG; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SURVIVAL RATE;

ADMINISTRATION, ORAL; ANIMALS; ANTI-INFECTIVE AGENTS; DRUG EVALUATION, PRECLINICAL; DRUG THERAPY, COMBINATION; ERYTHROMYCIN; FEMALE; FLUOROQUINOLONES; GUINEA PIGS; INJECTIONS, INTRAPERITONEAL; LEGIONELLA PNEUMOPHILA; LEGIONNAIRES' DISEASE; LUNG; MICROBIAL SENSITIVITY TESTS; PRODRUGS; RANDOM ALLOCATION; RIFAMPIN;

EID: 0031721870     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100960050100     Document Type: Article

References (12)

1. Meyer RD: Role of the quinolones in the treatment of legionellosis. Journal of Antimicrobial Chemotherapy (1991) 28:623-625
2. Fitzgeorge RB, Lever S, Baskerville A: A comparison of the efficacy of azithromycin and clarithromycin in oral therapy of experimental airborne Legionnaires' disease. Journal of Antimicrobial Chemotherapy (1993) 31, Supplement E: 171-176
3. Edelstein PH: Antimicrobial chemotherapy for Legionnaires' disease: a review. Clinical Infectious Diseases (1995) 21, Supplement 3:265-276
4. Briggs-Gooding B, Jones RN: In vitro antimicrobial activity of CP-99,219, a novel azabicyelo-naphthyridone. Antimicrobial Agents and Chemotherapy (1993) 37:366-370
5. Teng R, Harris SC, Nix DE, Schentag JJ, Foulds G, Liston TE: Pharmacokinetics and safety of trovafloxacin (CP-99,219), a new quinolone antibiotic, following administration of single oral doses to healthy male volunteers. Journal of Antimicrobial Chemotherapy (1995) 36:385-394
6. Teng R, Liston TE, Harris SC: Multiple-dose pharmacokinetics and safety of trovafloxacin in healthy volunteers. Journal of Antimicrobial Chemotherapy (1996) 7:955-963
7. Andrews JM, Honeybourne D, Brenwald NP, Bannerjee D, Iredale M, Cunningham D, Wise R: Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy. Journal of Antimicrobial Chemotherapy (1997) 39, Supplement B: 797-802
8. Fernandes PB, Bailer R, Swanson R: In vitro and in vivo evaluation of A-56268 (TE-031), a new macrolide. Antimicrobial Agents and Chemotherapy (1986) 30:865-873
9. National Committee for Clinical Laboratory Standards: Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved standard M-A2, NCCLS, Villanova, PA (1994)
10. Saito A, Koga H, Shigeno H, Watanabe K, Mori K, Kohno S: The antimicrobial activity of ciprofloxacin against Legionella species and the treatment of experimental Legionella pneumonia in guinea pigs. Journal of Antimicrobial Chemotherapy (1986) 18:251-260
11. Fitzgeorge RB, Featherstone ASR, Baskerville A: Efficacy of azithromycin in the treatment of guinea pigs infected with Legionella pneumophila by aerosol. Journal of Antimicrobial Chemotherapy (1990) 25, Supplement A: 101-108
12. Edelstein PH, Edelstein MAC, Ren J, Polzer R, Gladue RP: Activity of trovafloxacin (CP-99,219) against Legionella isolates: in vitro activity, intracellular accumulation and killing in macrophages, and pharmacokinetics and treatment of guinea pigs with Legionella pneumophila pneumonia. Antimicrobial Agents and Chemotherapy (1996) 40:314-319